Brittle Cornea Syndrome: Molecular Diagnosis and Management
- PMID: 40647596
- PMCID: PMC12249002
- DOI: 10.3390/diagnostics15131596
Brittle Cornea Syndrome: Molecular Diagnosis and Management
Abstract
Background and Clinical Significance: Brittle cornea syndrome (BCS) is a rare, autosomal recessive connective tissue disorder characterized by extreme corneal thinning, high myopia, and increased risk of spontaneous or trauma-induced ocular rupture. It is primarily caused by mutations in the ZNF469 or PRDM5 genes, which regulate extracellular matrix integrity. Early recognition and diagnosis of BCS are crucial to prevent severe visual impairment. This report presents two genetically confirmed cases of BCS in Albanian siblings, emphasizing the diagnostic value of whole-exome sequencing and individualized surgical management strategies. Case Presentation: Two siblings-a 28-year-old male and a 25-year-old female-presented with progressive visual deterioration and marked corneal thinning (<200 µm). Both had a history of spontaneous ocular rupture following minor trauma in the contralateral eye. Detailed ophthalmologic evaluation revealed keratoglobus, high myopia, and irregular astigmatism. Genetic testing identified the homozygous pathogenic variant c.974delG (p.Cys325LeufsX2) in the PRDM5 gene in both cases. The male underwent penetrating keratoplasty (PKP), achieving a best-corrected visual acuity (BCVA) of 20/30. The female initially underwent deep anterior lamellar keratoplasty (DALK), which was converted to PKP intraoperatively due to central endothelial perforation, resulting in a BCVA of 20/25. Both patients remained complication-free over a 7-year follow-up period. Conclusions: These cases highlight the importance of early genetic diagnosis and a tailored surgical approach in managing BCS. Long-term monitoring and protective strategies are essential to prevent complications. Incorporating genetic testing into clinical practice can enhance diagnostic accuracy and guide personalized treatment plans in patients with hereditary corneal dystrophies.
Keywords: PRDM5 gene; central corneal thinning; genetic corneal disease; irregular astigmatism; keratoglobus; pachymetry.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy.Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008420. doi: 10.1002/14651858.CD008420.pub2. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2014 Feb 14;(2):CD008420. doi: 10.1002/14651858.CD008420.pub3. PMID: 21735430 Updated.
-
A Novel Symptomatic Lecithin-Cholesterol Acyltransferase Gene Mutation With Corneal Amyloidosis.Cornea. 2024 Nov 1;43(11):1427-1430. doi: 10.1097/ICO.0000000000003671. Epub 2024 Aug 22. Cornea. 2024. PMID: 39177400
-
Brittle Cornea Syndrome Type 1 in Siblings: Severe Presentation in One and Misdiagnosis as Primary Congenital Glaucoma in the Other.Cornea. 2025 Jul 28. doi: 10.1097/ICO.0000000000003939. Online ahead of print. Cornea. 2025. PMID: 40719309
-
Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure.Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012097. doi: 10.1002/14651858.CD012097.pub2. Cochrane Database Syst Rev. 2018. PMID: 29940078 Free PMC article.
-
Artificial intelligence for detecting keratoconus.Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD014911. doi: 10.1002/14651858.CD014911.pub2. Cochrane Database Syst Rev. 2023. PMID: 37965960 Free PMC article.
References
-
- Dhooge T., Van Damme T., Syx D., Mosquera L.M., Nampoothiri S., Radhakrishnan A., Simsek-Kiper P.O., Utine G.E., Bonduelle M., Migeotte I., et al. More than meets the eye: Expanding and reviewing the clinical and mutational spectrum of brittle cornea syndrome. Hum. Mutat. 2021;42:711–730. doi: 10.1002/humu.24199. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources